{"id":"W3169161004","doi":"10.1200/jco.2021.39.15_suppl.586","title":"Impact of different sequencing strategies of talazoparib and carboplatin combination upon efficacy and toxicity in BRCA-wild type and BRCA-mutant triple-negative breast cancer models.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"Pfizer Canada","keywords":"Carboplatin; Medicine; PARP inhibitor; Olaparib; BRCA mutation; Concomitant; Cancer; Combination therapy; Population; Internal medicine; Ovarian cancer; Oncology; Breast cancer; Triple-negative breast cancer; Veliparib; Pharmacology; Cancer research; Chemotherapy; Biology; Poly ADP ribose polymerase; Cisplatin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002210964,0.0003884901,0.0003813535,0.0002739018,0.0001193299,0.0002845581,0.0003183863,0.0003545741,0.0008231308],"category_scores_gemma":[0.000172605,0.0001429755,0.0002477404,0.0002333569,0.0002356165,0.0002482164,0.0001131091,0.0005754626,0.0001414943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003196107,"about_ca_system_score_gemma":0.0003333951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001216027,"about_ca_topic_score_gemma":0.001960335,"domain_scores_codex":[0.9998349,0.0000336447,0.00001471839,0.00003867233,0.00003429758,0.00004372038],"domain_scores_gemma":[0.9998577,0.00002710004,0.00004158497,0.00001526377,0.00001750408,0.00004088064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003857984,0.001610481,0.0006506161,0.00010225,0.00004968134,0.0000530339,0.00005554969,0.001535869,0.9837837,0.0000944505,0.0002558207,0.007950451],"study_design_scores_gemma":[0.00021956,0.01336614,0.002533087,0.000006533374,0.00009126603,0.0001221266,0.00003291972,0.00175508,0.980565,0.00003120063,0.001261529,0.00001554473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977682,0.0006183427,0.0005383984,0.00004995894,0.00002732438,0.00005924165,0.0002540795,0.00004777523,0.000636711],"genre_scores_gemma":[0.9958214,0.0008549425,0.001764061,0.00005045522,0.00001372682,0.00009639384,0.0003460729,0.00002483466,0.001028156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001216027,"threshold_uncertainty_score":0.002753675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1231611615651621,"score_gpt":0.4682478282487527,"score_spread":0.3450866666835906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}